To evaluate whether B-ALL cell interaction with MSC was affected by PKC inhibition, we first treated the MSC with ENZA for 48 h in two conditions, 1% or 10% FBS, and showed that B-ALL cell adhesion was highly affected (Figure 4A). Here, PRRT2 is linked to acute lymphoblastic leukemia.